FERRACINI, RICCARDO
 Distribuzione geografica
Continente #
EU - Europa 6.918
Totale 6.918
Nazione #
IT - Italia 6.918
Totale 6.918
Città #
Genova 5.399
Rapallo 731
Genoa 641
Vado Ligure 119
Bordighera 28
Totale 6.918
Nome #
Increased circulating osteoclast precursors and activated T cells are involved in bone impairment in phenylketonuria 1.143
Three-Dimensional Craniofacial Bone Reconstruction With SmartBone on Demand 154
C-met inhibition blocks bone metastasis development induced by renal cancer stem cells 113
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib 107
DISSECTION OF THE ANTIGENIC DETERMINANTS EXPRESSED ON THE CELL-SURFACE OF RSV-TRANSFORMED FIBROBLASTS BY MONOCLONAL-ANTIBODIES 105
Exercise therapy indications in metastatic bone patients 105
Scaffolds as structural tools for bone-targeted drug delivery 104
Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues. 103
THE TYROSINE KINASE ENCODED BY THE MET PROTOONCOGENE IS ACTIVATED BY AUTOPHOSPHORYLATION 102
Assessment of vascularized fibular graft one year after reconstruction of the wrist after excision of a giant-cell tumour 102
Concentrated adipose tissue infusion for the treatment of knee osteoarthritis: clinical and histological observations 102
Bone metastases in gastric cancer follow a RANKL-independent mechanism 101
Bone invading NSCLC cells produce IL-7: mice model and human histologic data 100
Does metal porosity affect metal ion release in blood and urine following total hip arthroplasty? A short term study 99
IMMUNOLOGICAL DETECTION OF PROTEINS PHOSPHORYLATED AT TYROSINE IN CELLS STIMULATED BY GROWTH-FACTORS OR TRANSFORMED BY RETROVIRAL-ONCOGENE-CODED TYROSINE KINASES 97
Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures 96
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement 96
IL-7 modulates osteoclastogenesis in patients affected by solid tumors 96
A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging 96
Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase 94
Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs 92
Osteogenic differentiation modulates the cytokine, chemokine, and growth factor profile of ASCs and SHED 92
Primary breast cancer stem-like cells metastasise to bone, switch phenotype and acquire a bone tropism signature 91
A CELL-SURFACE INTEGRAL MEMBRANE GLYCOPROTEIN OF 85,000 MOL WT (GP85) ASSOCIATED WITH TRITON X-100-INSOLUBLE CELL SKELETON 91
Tripled semitendinosus with single harvesting is as effective but less invasive compared to standard gracilis-semitendinosus harvesting 90
PMMA-based bone cements and the problem of joint arthroplasty infections: Status and new perspectives 90
Microenvironment-modulated metastatic CD133+/CXCR4+/EpCAM-lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis 89
MET overexpression turns human primary osteoblasts into osteosarcomas 88
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 88
Adipose Derived-Mesenchymal Stem Cells Viability and Differentiating Features for Orthopaedic Reparative Applications: Banking of Adipose Tissue 88
Iloprost modulates the immune response in systemic sclerosis 87
Teriparatide increases the maturation of circulating osteoblast precursors 87
P145, A PROTEIN WITH ASSOCIATED TYROSINE KINASE-ACTIVITY IN A HUMAN GASTRIC-CARCINOMA CELL-LINE 85
Bone Metastasis from Solid Tumors: Biologic and Clinical State of the Art 85
Osteoclasts Are Active in Bone Forming Metastases of Prostate Cancer Patients 85
Increased spontaneous osteoclastogenesis from peripheral blood mononuclear cells in phenylketonuria 83
Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma 81
MET oncogene aberrant expression in canine osteosarcoma 81
Evaluation of the Effectiveness of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty: A Meta-Analysis 77
Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration 76
Regeneration of articular cartilage: Scaffold used in orthopedic surgery. A short handbook of available products for regenerative joints surgery 75
DKK-1 in prostate cancer diagnosis and follow up 74
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement 74
Cancer Stem cells promote bone metastases in osteotropic tumors. 72
IL-7 Up-Regulates TNF-alpha-Dependent Osteoclastogenesis in Patients Affected by Solid Tumor 66
Solid tumours show osteotropism: Mechanisms of bone metastases 66
Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer 66
Distal ulnar tumours - Results of management by en bloc resection in nine patients and review of the literature 64
Anergic bone marrow V gamma 9V delta 2 Tcells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma 60
Expression of met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors 60
MONOCLONAL-ANTIBODIES AGAINST CELL-SURFACE ANTIGENS OF ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS 56
Capsular replacement with synthetic mesh - Effectiveness in preventing postoperative dislocation after wide resection of proximal femoral tumors and prosthetic reconstruction 55
ANALYSIS OF MUTANT FORMS OF THE C-SRC GENE-PRODUCT CONTAINING A PHENYLALANINE SUBSTITUTION FOR TYROSINE-416 54
The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespective of the disease status 54
PROTEIN-PHOSPHORYLATION AT TYROSINE RESIDUES IN V-ABL TRANSFORMED MOUSE LYMPHOCYTES AND FIBROBLASTS 53
The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors 51
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas 51
A novel method to optimize autologous adipose tissue recovery with extracellular matrix preservation 51
THE MET/HGF RECEPTOR IS OVER-EXPRESSED IN HUMAN OSTEOSARCOMAS AND IS ACTIVATED BY EITHER A PARACRINE OR AN AUTOCRINE CIRCUIT 50
Reversal of multidrug-resistance using Valspodaro (R) (PSC 833) and doxorubicin in osteosarcoma 50
Cancer stem cells, bone and tumor microenvironment: Key players in bone metastases 49
A radiological approach to evaluate bone graft integration in reconstructive surgeries 47
NUCLEAR IMMUNOLOCALIZATION OF P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CELL-LINES SHOWING SIMILAR MECHANISMS OF DOXORUBICIN DISTRIBUTION 45
THE 27 KD PROTEIN ENCODED BY THE HIV NEF GENE SHARES STRUCTURAL AND FUNCTIONAL HOMOLOGIES WITH SEVERAL ONCOGENE PRODUCTS 44
Bone impairment and osteoclastogenesis in phenylalanine hydroxylase deficiency 43
INTRACELLULAR CALCIUM REGULATES THE TYROSINE KINASE RECEPTOR ENCODED BY THE MET ONCOGENE 42
L’uso di cellule staminali di derivazione adiposa in ortopedia. Indicazioni e limiti normativi. 42
Is the adipose-derived mesenchymal stem cell therapy effective for treatment of knee osteoarthritis? 41
'OSTEO-ONCOLOGY MULTIDISCIPLINARY CARE GROUP': A NOVEL APPROACH TO THE METASTATIC AND PRIMARY BONE TUMOR PATIENT. THE MOLINETTE EXPERIENCE 40
IDENTIFICATION OF THE MAJOR AUTOPHOSPHORYLATION SITE OF THE MET HEPATOCYTE GROWTH-FACTOR RECEPTOR TYROSINE KINASE 40
The multidisciplinary approach to the osteo-oncologic patient: Management and cost 40
The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors 39
Mechanisms of bone metastases in gastric carcinoma (gc): preliminary results of a biological and clinical study. 38
CLINICAL EVALUATION STUDY OF PRESENTATION, CLINICAL EVOLUTION, INCIDENCE OF SKELETAL COMPLICATIONS AND TREATMENTS OF BONE METASTASES: PRELIMINARY DATA 38
PRODUCTION OF MONOCLONAL-ANTIBODIES TO HUMAN FIBRONECTIN 37
CXCR4 inhibition counteracts immunosuppressive properties of metastatic NSCLC stem cells 35
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 33
Simulated performance of a xenohybrid bone graft (Smartbone®) in the treatment of acetabular prosthetic reconstruction 30
IDENTIFICATION OF ANDROGEN RECEPTORS IN SYNOVIAL MACROPHAGE-LIKE CELLS - SIGNIFICANCE IN RHEUMATOID-ARTHRITIS 29
Composite xenohybrid bovine bone-derived scaffold as bone substitute for the treatment of tibial plateau fractures 29
Spontaneous osteoclastogenesis in solid tumours with bone involvement. 27
Ceramic-on-ceramic catastrophic liner failure in total hip arthroplasty: Morphological and compositional analysis of fractured ceramic components 24
RESURFACED ALLOGRAFTS FOR THE RECONSTRUCTION OF THE KNEE AFTER ONCOLOGIC RESECTION IN GROWING CHILDREN 23
Biomimetic Citrate-Coated Luminescent Apatite Nanoplatforms for Diclofenac Delivery in Inflammatory Environments 22
Treatment of knee osteoarthritis by intra-articular injection of concentrated autologous adipose tissue: a twenty four month follow-up study 20
Murine models to study human NK cells in human solid tumors 18
Reconstructive options in lower limb surgery for primary bone tumors in the skeletally immature patients 18
Age and synovitis affect the results of the treatment of knee osteoarthritis with Microfragmented Autologous Fat Tissue 17
MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE REPRESENT AN ASSET FOR ORTHOPAEDIC REGENERATIVE 17
Functional results of allograft vs. autograft tendons in anterior cruciate ligament (ACL) reconstruction at 10-year follow-up 17
The effectiveness of shoe modifications and orthotics in the conservative treatment of civinini-morton syndrome: State of art 16
Rehabilitation Protocol after Hip Arthroscopy: A 2015-2020 Systematic Review 14
Totale 7.057
Categoria #
all - tutte 23.626
article - articoli 21.278
book - libri 0
conference - conferenze 2.348
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.269 0 0 81 165 193 266 484 210 221 317 239 93
2020/2021848 38 152 173 58 66 48 18 74 36 112 33 40
2021/20221.125 41 90 88 89 45 110 54 221 100 106 61 120
2022/2023866 94 15 7 56 110 189 5 47 195 2 134 12
2023/2024532 34 83 7 77 47 99 23 40 17 25 30 50
2024/2025124 11 113 0 0 0 0 0 0 0 0 0 0
Totale 7.057